Scaling Cell and Gene Therapy Manufacturing

Wednesday, July 22, 2026Corinna Singleman, PhDView original

Cell and gene therapy leaders discuss the industry’s biggest bioprocessing challenges, from manufacturing scalability and raw-material variability to infrastructure readiness, and explain the strategies they believe will accelerate commercialization and improve patient access.

The post Scaling Cell and Gene Therapy Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News.